By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genome British Columbia has started a new Personalized Medicine Program, which includes financial support from the non-profit BC Cancer Foundation, by awarding an initial investment of around C$9 million ($9.4 million) in funding to three studies.

The new program seeks to use genomics research to tailor improved treatments for patients, to mitigate ineffective treatments and side effects, and to use genomic knowledge in disease prevention and early diagnosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.